Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
3.788
+0.028 (0.73%)
Aug 15, 2025, 9:43 AM - Market open
Galectin Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 13.77 | 15.12 | 25.66 | 18.59 | 39.65 | 27.14 | Upgrade
|
| Cash & Short-Term Investments | 13.77 | 15.12 | 25.66 | 18.59 | 39.65 | 27.14 | Upgrade
|
| Cash Growth | -46.20% | -41.08% | 38.02% | -53.11% | 46.08% | -42.84% | Upgrade
|
| Prepaid Expenses | 1.66 | 1.03 | 2.04 | 1.95 | 2.17 | 2.32 | Upgrade
|
| Other Current Assets | - | 1.11 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Current Assets | 15.43 | 17.25 | 27.71 | 20.55 | 41.82 | 29.47 | Upgrade
|
| Property, Plant & Equipment | - | 0.02 | 0.05 | 0.09 | - | - | Upgrade
|
| Other Long-Term Assets | 0.18 | 0.23 | 0.44 | 0.65 | 0.01 | 0.14 | Upgrade
|
| Total Assets | 15.6 | 17.5 | 28.2 | 21.29 | 41.83 | 29.6 | Upgrade
|
| Accounts Payable | 5.87 | 5.66 | 6.43 | 3.89 | 1.81 | 1.29 | Upgrade
|
| Accrued Expenses | 4.85 | 8.19 | 9.14 | 9.02 | 7.16 | 4 | Upgrade
|
| Current Portion of Long-Term Debt | - | 21.12 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | 0.02 | 0.05 | 0.04 | 0.01 | 0.04 | Upgrade
|
| Other Current Liabilities | 0.06 | 0.43 | 0.06 | 0.06 | 0.07 | 0.07 | Upgrade
|
| Total Current Liabilities | 10.77 | 35.41 | 15.68 | 13.01 | 9.03 | 5.4 | Upgrade
|
| Long-Term Debt | 120.46 | 85.11 | 71.74 | 39.83 | 29.05 | - | Upgrade
|
| Long-Term Leases | - | - | 0.02 | 0.07 | - | 0.01 | Upgrade
|
| Other Long-Term Liabilities | 1.54 | 0.05 | 1 | 0.57 | 1.13 | - | Upgrade
|
| Total Liabilities | 132.77 | 120.57 | 88.44 | 53.48 | 39.21 | 5.41 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 299.32 | 296.22 | 291.85 | 275.08 | 271 | 261.88 | Upgrade
|
| Retained Earnings | -418.76 | -401.57 | -354.37 | -309.57 | -270.69 | -240 | Upgrade
|
| Total Common Equity | -119.38 | -105.29 | -62.46 | -34.43 | 0.37 | 21.94 | Upgrade
|
| Shareholders' Equity | -117.17 | -103.07 | -60.24 | -32.19 | 2.62 | 24.19 | Upgrade
|
| Total Liabilities & Equity | 15.6 | 17.5 | 28.2 | 21.29 | 41.83 | 29.6 | Upgrade
|
| Total Debt | 120.46 | 106.25 | 71.81 | 39.93 | 29.06 | 0.05 | Upgrade
|
| Net Cash (Debt) | -106.69 | -91.13 | -46.15 | -21.34 | 10.59 | 27.09 | Upgrade
|
| Net Cash Growth | - | - | - | - | -60.90% | -42.90% | Upgrade
|
| Net Cash Per Share | -1.70 | -1.46 | -0.77 | -0.36 | 0.18 | 0.48 | Upgrade
|
| Filing Date Shares Outstanding | 64.06 | 63.18 | 61.9 | 59.44 | 59.36 | 57.16 | Upgrade
|
| Total Common Shares Outstanding | 64.06 | 63.16 | 61.85 | 59.43 | 59.34 | 57.08 | Upgrade
|
| Working Capital | 4.65 | -18.16 | 12.03 | 7.54 | 32.79 | 24.07 | Upgrade
|
| Book Value Per Share | -1.86 | -1.67 | -1.01 | -0.58 | 0.01 | 0.38 | Upgrade
|
| Tangible Book Value | -119.38 | -105.29 | -62.46 | -34.43 | 0.37 | 21.94 | Upgrade
|
| Tangible Book Value Per Share | -1.86 | -1.67 | -1.01 | -0.58 | 0.01 | 0.38 | Upgrade
|
| Machinery | - | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
| Leasehold Improvements | - | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.